000 | 01970 a2200589 4500 | ||
---|---|---|---|
005 | 20250515022337.0 | ||
264 | 0 | _c20070119 | |
008 | 200701s 0 0 eng d | ||
022 | _a0167-6806 | ||
024 | 7 |
_a10.1007/s10549-006-9210-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBu, Dawei | |
245 | 0 | 0 |
_aAn intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. _h[electronic resource] |
260 |
_bBreast cancer research and treatment _cOct 2006 |
||
300 |
_a257-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdenine |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aBenzo(a)pyrene _xpharmacology |
650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
650 | 0 | 4 |
_aCarcinogens _xpharmacology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aGuanine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntrons _xgenetics |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 |
_aMesylates _xpharmacology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 | _aX-ray Repair Cross Complementing Protein 1 |
700 | 1 | _aTomlinson, Gail | |
700 | 1 | _aLewis, Cheryl M | |
700 | 1 | _aZhang, Cindy | |
700 | 1 | _aKildebeck, Eric | |
700 | 1 | _aEuhus, David M | |
773 | 0 |
_tBreast cancer research and treatment _gvol. 99 _gno. 3 _gp. 257-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-006-9210-3 _zAvailable from publisher's website |
999 |
_c16202148 _d16202148 |